Wang et al. conjugated pomalidomide with a FOXM1-binding antagonistic peptide to synthesize a novel FOXM1-targeted p-PROTAC that successfully suppressed the viability, migration, and invasion of various cancers 57. Here, FOXM1 is linked to cancer.